NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Integrated Mindfulness-based Health Qigong Intervention for COVID-19 Survivors and Caregivers

NCT06194357

CompletedNA

Sponsor: TSANG Hector Wing-Hong

Conditions: COVID-19 Infection

Interventions: Mindfulness-based Health Qigong Intervention

Countries: Hong Kong

This study examines the effectiveness of a 16-week Integrated Mindfulness-based Health Qigong (iMBHQ) program, delivered via a mobile application, in improving the mental and physical well-being of COVID-19 survivors, their caregivers, and the general public. We hypothesize that participants in the iMBHQ group will demonstrate significant reductions in stress, depression, and anxiety compared to a control group receiving treatment-as-usual. This parallel-group randomized controlled trial aims to recruit 600 participants (200 COVID-19 survivors, 200 caregivers, and 200 individuals from the general public). Effectiveness is evaluated at baseline, 8 weeks, 16 weeks, 6 months, and 12 months post-intervention, using standardized psychological and physical health assessments.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* COVID-19 survivors: people aged 18 years or above who were infected by COVID-19 (both symptomatic and asymptomatic) and clinically recovered
* Caregivers of COVID-19 patients, including family members or medical professionals who have contacts with patients diagnosed COVID-19 aged 18 years or above
* General healthy public aged 18 years or above

Exclusion Criteria:

* people diagnosed severe and/or chronic conditions that prevent the practice of Qigong (e.g., acute exacerbation of dyspnoea, severe cardiopulmonary disease) or mindfulness intervention,
* people with severe psychiatric disorder
* people who have regular psychiatric follow-ups

Locations (2)

Hong Kong, Hong Kong
Hong Kong, Hong Kong